Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus Capsules for Vulvovaginal Atrophy in Breast Cancer
NCT05974449Phase 2Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Aug 2023
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in Vulvovaginal atrophy (VVA) (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoints: Vaginal PH at 1 year and Functional Assessment of Cancer Therapy - Endocrine Symptoms at 1 year. Started Aug 2023; status: recruiting.
02
Conditions
Vulvovaginal atrophy (VVA)
Beyond the preview
Go deeper on NCT05974449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05974449.